A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection-Reference-Cited by-同舟云学术

A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection

Published:2023-12 Issue: Volume:31 Page:101110
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Boulton Stephen^ORCID,Poutou Joanna,Gill Rida,Alluqmani Nouf,He Xiaohong,Singaravelu Ragunath,Crupi Mathieu J.F.,Petryk Julia,Austin Bradley,Angka Leonard,Taha Zaid,Teo Iris,Singh Siddarth,Jamil Rameen,Marius Ricardo,Martin Nikolas,Jamieson Taylor,Azad Taha,Diallo Jean-Simon,Ilkow Carolina S.,Bell John C.

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference84 articles.

1. Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines;Zhang;Front. Immunol.,2021

2. Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles;Syed;Proc. Natl. Acad. Sci. USA,2022

3. Current evidence on efficacy of COVID-19 booster dose vaccination against the Omicron variant: A systematic review;Chenchula;J. Med. Virol.,2022

4. Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5;Hachmann;N. Engl. J. Med.,2022

5. Bivalent Covid-19 Vaccines — A Cautionary Tale;Offit;N. Engl. J. Med.,2023

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy;Nature Communications;2024-08-23

2. Lessons from COVID‐19: Aspects of prevention, therapeutics, and diagnostics against SARS‐CoV‐2 with special focus on JN.1 and XBB sublineages;MedComm – Future Medicine;2024-06

3. Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines;Autoimmunity Reviews;2024-03